ARS Pharmaceuticals Inc. (SPRY) PE Ratio
ARS Pharmaceuticals Inc. (SPRY) PE ratio history, current valuation, and earnings analysis. Track price-to-earnings trends in Excel with MarketXLS.
PE Ratio Data
| Period | PE Ratio |
|---|---|
| 2021-12-31 | -3.67 |
| 2022-12-31 | -10.80 |
| 2023-12-31 | -16.49 |
| 2024-12-31 | 117.50 |
| 2025-12-31 | -5.40 |
Get ARS Pharmaceuticals Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =PERatio("SPRY")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | SPRY | $9.40 | +10.59% | 2.61M |
| 3 | ||||
| 4 | ||||
| 5 |